Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report

Vaccination-induced demyelination is a rare, unusual side effect of certain vaccines which can cause significant damage to patient’s sensory-motor abilities within days. Although COVID-19 vaccines go through rigorous clinical trials before they are injected to the general population, certain unexpec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirmosayyeb, Omid, Bagherieh, Sara, Shaygannejad, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567291/
https://www.ncbi.nlm.nih.gov/pubmed/34714721
http://dx.doi.org/10.1080/21645515.2021.1971920
_version_ 1784594200914821120
author Mirmosayyeb, Omid
Bagherieh, Sara
Shaygannejad, Vahid
author_facet Mirmosayyeb, Omid
Bagherieh, Sara
Shaygannejad, Vahid
author_sort Mirmosayyeb, Omid
collection PubMed
description Vaccination-induced demyelination is a rare, unusual side effect of certain vaccines which can cause significant damage to patient’s sensory-motor abilities within days. Although COVID-19 vaccines go through rigorous clinical trials before they are injected to the general population, certain unexpected side effects remain inevitable. We herein describe a case of a 42-year-old woman who experienced acute demyelination 10 days after the Oxford-AstraZeneca vaccination. To the best of our knowledge, this is the first case of such nature and severity described regarding COVID-19 vaccines’ side effects.
format Online
Article
Text
id pubmed-8567291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-85672912021-11-05 Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report Mirmosayyeb, Omid Bagherieh, Sara Shaygannejad, Vahid Hum Vaccin Immunother Case Report Vaccination-induced demyelination is a rare, unusual side effect of certain vaccines which can cause significant damage to patient’s sensory-motor abilities within days. Although COVID-19 vaccines go through rigorous clinical trials before they are injected to the general population, certain unexpected side effects remain inevitable. We herein describe a case of a 42-year-old woman who experienced acute demyelination 10 days after the Oxford-AstraZeneca vaccination. To the best of our knowledge, this is the first case of such nature and severity described regarding COVID-19 vaccines’ side effects. Taylor & Francis 2021-10-29 /pmc/articles/PMC8567291/ /pubmed/34714721 http://dx.doi.org/10.1080/21645515.2021.1971920 Text en © 2021 Taylor & Francis Group, LLC
spellingShingle Case Report
Mirmosayyeb, Omid
Bagherieh, Sara
Shaygannejad, Vahid
Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title_full Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title_fullStr Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title_full_unstemmed Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title_short Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
title_sort acute cns demyelination in a subject with cerebellar ataxia following the first dose of covid-19 vaccine; a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567291/
https://www.ncbi.nlm.nih.gov/pubmed/34714721
http://dx.doi.org/10.1080/21645515.2021.1971920
work_keys_str_mv AT mirmosayyebomid acutecnsdemyelinationinasubjectwithcerebellarataxiafollowingthefirstdoseofcovid19vaccineacasereport
AT bagheriehsara acutecnsdemyelinationinasubjectwithcerebellarataxiafollowingthefirstdoseofcovid19vaccineacasereport
AT shaygannejadvahid acutecnsdemyelinationinasubjectwithcerebellarataxiafollowingthefirstdoseofcovid19vaccineacasereport

Ejemplares similares